Abstract
The aim of this study was to evaluate in vitro skin permeation and deposition, in vivo toxicokinetics, percutaneous absorption and tissue distribution of benzophenone-3 (BP-3) in rats. Four transdermal formulations containing BP-3 were prepared and evaluated for in vitro skin permeation and deposition of BP-3 using Franz diffusion cells. A gel formulation was used in subsequent in vivo percutaneous absorption due to its high in vitro skin permeation and deposition. Compared to intravenous (i.v.) injection, the prolonged terminal t1/2 (3.1 ± 1.6 h for i.v. injection and 18.3 ± 5.8 h for topical application) was observed indicating occurrence of flip-flop kinetics after topical application. The bioavailability of BP-3 after topical application was 6.9 ± 1.8%. The tissue-to-plasma partition coefficient (kp) for testis, considered a toxic target for BP-3, was less than 1. Overall, findings of this study may be useful for risk assessment of BP-3.
Funder
Ministry of Food and Drug Safety, Republic of Korea
Subject
Chemical Health and Safety,Health, Toxicology and Mutagenesis,Toxicology
Reference38 articles.
1. Final report on the safety assessment of benzophenones-1,-3,-4,-5,-9, and-11;J. Am. College Toxicol,1983
2. Ultraviolet light induced injury: Immunological and inflammatory effects;Immunol. Cell Biol.,2001
3. Photocarcinogenesis: UVA vs. UVB radiation;Ski. Pharmacol. Physiol.,2002
4. Comparison of methods for assessing photoprotection against ultraviolet A in vivo;J. Am. Acad. Dermatol.,1987
5. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation;Br. J. Dermatol.,2006
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献